Clinical Trials Logo

Clinical Trial Summary

This study aims to determine how a 12-week magnesium supplementation with 400 mg magnesium from organic magnesium citrate affects blood glucose control and insulin resistance within patients with type 2 diabetes (HbA1c> 6%) and how the expression of certain Mg-sensitive transporting genes is affected .

Clinical Trial Description

The examinations are carried out in 50 subjects aged 20-80 years with existing type 2 diabetes (HbA1c> 6%). The target parameters are determined in the blood. Blood sampling takes place at confinement, after 6 weeks and at the end of the study (week 12). In addition, blood pressure is determined and general health condition of each subject is recorded by a standardized questionnaire (SF-36). ;

Study Design

Related Conditions & MeSH terms

NCT number NCT03002545
Study type Interventional
Source Protina Pharmazeutische GmbH
Status Completed
Phase N/A
Start date December 2016
Completion date July 2019